Skip to search formSkip to main contentSkip to account menu

pidotimod

Known as: 3-((5-oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid, 3-pyroglutamylthiazolidine-4-carboxylic acid, PGT-1A 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (4)

Immunologic AdjuvantsImmunologic FactorsPyrrolidonecarboxylic AcidThiazolidines
Pyroglutamateanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Studies on Pidotimod Enantiomers With Chiralpak-IA: Crystal Structure, Thermodynamic Parameters and Molecular Docking.
Pidotimod, a synthetic dipeptide, has two chiral centers with biological and immunological activity. Its enantiomers were… 
2014
2014
Pidotimod may prevent recurrent respiratory infections in children.
AIM Recurrent respiratory infections (RRI) constitute a social problem for both the pharmaco-economic impact and the burden for… 
Highly Cited
2008
Highly Cited
2008
Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression
We investigated the synergistic effect of combined treatment with red ginseng acidic polysaccharide (RGAP) from Panax ginseng C.A… 
2004
2004
Immune Modulator Pidotimod Decreases the In Vitro Expression of CD30 in Peripheral Blood Mononuclear Cells of Atopic Asthmatic and Normal Children
Recurrent viral infections are frequently observed in children with atopic asthma. In this study we investigated the ability of… 
2002
2002
Clinical evaluation and changes of the respiratory epithelium function after administration of Pidotimod in Greek children with recurrent respiratory tract infections.
BACKGROUND Several studies have been conducted on young children with recurrent respiratory infections using several compounds… 
1994
1994
Immunoactivation by pidotimod in children with recurrent respiratory infections.
The therapeutic activity and safety of pidotimod ((R)-3-[(S)-(5-oxo-2-pyrrolidinyl) carbonyl]-thiazolidine-4-carboxylic acid, PGT… 
1994
1994
Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
The activity of pidotimod ((R)-3-[(S)-(5-oxo-2-pyrrolidinyl) carbonyl]-thiazolidine-4-carboxylic acid, PGT/1A, CAS 121808-62-6… 
1994
1994
Immunomodulating activity of pidotimod.
Experiments were performed to analyze the effect of the immunomodulating agent pidotimod ((R)-3-[(S)-(5-oxo-2-pyrrolidinyl… 
1994
1994
Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
The efficacy and safety of a new synthetic immunostimulant pidotimod ((R)-3-[(S)-(5-oxo-2-pyrrolidinyl) carbonyl]-thiazolidine-4… 
1992
1992
Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death.
Experiments were performed to analyze the possible effect of the immunomodulating agent Pidotimod (3-L-pyroglutamyl-L… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)